Several mouse models implicate a role for RIP1 and RIP3 in human diseases like epidermal hyperplasia, liver injury, and atherosclerosis (4); however, a specific cellular mechanism of action of RIP1 in these disease models remains elusive. This evidence concerns the gene RIPK1 and atherosclerosis.